BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7970709)

  • 41. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of c-myc expression by Ras/Raf signalling.
    Kerkhoff E; Houben R; Löffler S; Troppmair J; Lee JE; Rapp UR
    Oncogene; 1998 Jan; 16(2):211-6. PubMed ID: 9464539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple pathways for activation of MAP kinases.
    Mitra G; Weber M; Stacey D
    Cell Mol Biol Res; 1993; 39(5):517-23. PubMed ID: 8173594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
    Majewski M; Nieborowska-Skorska M; Salomoni P; Slupianek A; Reiss K; Trotta R; Calabretta B; Skorski T
    Cancer Res; 1999 Jun; 59(12):2815-9. PubMed ID: 10383138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A dominant suppressive mutation in a cellular gene restores the nontransformed phenotype to v-fms-transformed mink cells.
    Kato J; Sherr CJ
    Oncogene; 1991 May; 6(5):687-93. PubMed ID: 2052353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes.
    Stacey DW; Roudebush M; Day R; Mosser SD; Gibbs JB; Feig LA
    Oncogene; 1991 Dec; 6(12):2297-304. PubMed ID: 1766676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rac1 and extracellularly regulated kinase activation are sufficient for E1A-dependent cooperative transformation of primary epithelial cells, but progression can only be modulated by E1A or Rac1.
    Fischer RS; Zheng Y; Quinlan MP
    Cell Growth Differ; 1998 Mar; 9(3):209-21. PubMed ID: 9543387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
    Yanagihara K; Ciardiello F; Talbot N; McGeady ML; Cooper H; Benade L; Salomon DS; Bassin RH
    Oncogene; 1990 Aug; 5(8):1179-86. PubMed ID: 2202950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic effect of the v-myc oncogene with H-ras on radioresistance.
    McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ
    Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
    Vennström B; Bravo R
    Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transformation of T lymphocytes by the v-fos oncogene.
    Valge-Archer VE; de Villiers J; Sinskey AJ; Rao A
    J Immunol; 1990 Dec; 145(12):4355-64. PubMed ID: 2124241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gangliosides in human urothelial cell lines of different transformed phenotypes: the effect of v-raf-oncogene transfection.
    Ugorski M; Dus D; Skouv J; Påhlsson P; Radzikowski C
    Anticancer Res; 1989; 9(6):1583-6. PubMed ID: 2627112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retroviral v-myc infection of primary fetal liver cells: transformation of monocytes in vitro.
    Birchenall-Roberts MC; Engelmann GL; Keller JR; Lohrey N; Ruscetti FW
    Oncogene; 1989 Jun; 4(6):731-5. PubMed ID: 2786619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and rat 1a cells.
    Gallego C; Gupta SK; Heasley LE; Qian NX; Johnson GL
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7355-9. PubMed ID: 1323832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ; Heaney ML; Parsons JT
    Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes.
    Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T
    Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathology of spontaneous and oncogene transformed rat liver epithelial cells and derived tumours in nude mice.
    Williams AO; Huggett AC; Thorgeirsson SS
    Int J Exp Pathol; 1992 Feb; 73(1):99-114. PubMed ID: 1576082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance to transformation by insertionally activated c-erbB is a dominant phenotype in fibroblasts.
    Carter TH; Dominguez N; Zeng L; Kung HJ
    Virology; 1995 Sep; 212(1):277-83. PubMed ID: 7676646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
    Zerlin M; Julius MA; Cerni C; Marcu KB
    Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo and in vitro effects of v-fos and EJ-Ha-ras oncogene expression in murine epidermal keratinocytes.
    Appleby MW; Greenfield IM; Crook T; Parkinson EK; Stanley MA
    Oncogene; 1989 Nov; 4(11):1323-30. PubMed ID: 2682460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.